These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27134890)

  • 1. Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap.
    Kumar P; Chauhan A; Charaniya R; Ghosh A; Tandon V
    J Clin Diagn Res; 2016 Mar; 10(3):FD01-2. PubMed ID: 27134890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
    Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chantaphakul H; Sanon T; Klaewsongkram J
    Exp Ther Med; 2015 Aug; 10(2):519-524. PubMed ID: 26622347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients.
    Rattanakaemakorn P; Palakornkitti P; Pinyowiwat P; Jedee P; Thadanipon K
    Front Med (Lausanne); 2022; 9():939210. PubMed ID: 36091688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicoetiological Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Spectrum and the Correlation of SCORTEN with Prognosis.
    Kanagarajan A; Murthy AB; Moni PK; Palanivel N
    Indian J Dermatol; 2023; 68(1):25-33. PubMed ID: 37151260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients.
    Erduran F; Adışen E; Emre S; Hayran Y; Başkan EB; Yazıcı S; Bilgiç A; Alpsoy E; Günaydın SD; Elmas L; Akyol M; Güner R; Arıca DA; Aypek Y; Ergun T; Karavelioğlu D; Yazıcı AC; Aydoğan K; Bayramgürler D; Kıran R; Erdoğan HK; Acer E; Aktaş A
    Dermatol Ther (Heidelb); 2024 Jun; 14(6):1547-1560. PubMed ID: 38758423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.
    Sethuraman G; Sharma VK; Pahwa P; Khetan P
    Indian J Dermatol; 2012 May; 57(3):199-200. PubMed ID: 22707771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
    Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
    JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of Nonprescription Medication and Antibiotic Use in Patients with Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Overlap Syndrome.
    Sullivan KJ; Jeffres MN; Dellavalle RP; Valuck R; Anderson HD
    Antibiotics (Basel); 2018 Feb; 7(1):. PubMed ID: 29389866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease severity and status in Stevens-Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs.
    Lehloenya RJ
    Front Med (Lausanne); 2022; 9():901401. PubMed ID: 36172538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.